Akebia Therapeutics akebia.com


Public list: BIO 2016 (619) Pharma Startups (4500)

Akebia Therapeutics is a biopharmaceutical company focused on the development of small molecules for the treatment of anemia and vascular disease. The company's lead compound, AKB-6548, is a once daily, oral HIF2 stabilizing agent (HIF-PH inhibitor) in phase 2 clinical trials for chronic anemia. Akebia also has a platform of HPTPß inhibitors / Angiopoietin 2 modulators which have demonstrated preclinical proof of concept in vascular leak, angiogenesis and as anti-metastatic agents. Akebia Thera...Show all

Akebia Therapeutics is a biopharmaceutical company focused on the development of small molecules for the treatment of anemia and vascular disease. The company's lead compound, AKB-6548, is a once daily, oral HIF2 stabilizing agent (HIF-PH inhibitor) ...Show all

Company (IPO / Went public)

All investors data 14 Investors

Phone: 513-985-1920

Fax:

9987 Carver Road
Suite 420
 Cincinnati, 45242
 Ohio, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Akebia Therapeutics $195.3M Mar 21, 2014
Humanetics Corporation $0.6M Aug 10, 2016
Affinium Pharmaceuticals $44.9M Sep 12, 2013
See all 33 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Akebia Therapeutics Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 14 investors

Board Members

Name Firm
Login to see detailsKearny Venture Partners
Login to see detailsNovartis Venture Funds
Login to see detailsSpring Mill Venture Partners
Login to see detailsVenture Investors

Competitors

Company Status Description Investors
See all 33 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Prolyl hydroxylase inhibitors and methods of use Sep 15, 2015 Mar 21, 2017 Patent
Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides Jun 05, 2012 Sep 29, 2015 Patent
Prolyl hydroxylase inhibitors and methods of use Oct 24, 2013 Jan 27, 2015 Patent
Compounds and compositions for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer Jun 05, 2012 Oct 21, 2014 Patent
Prolyl hydroxylase inhibitors and method of use Apr 09, 2013 May 13, 2014 Patent
See all 17 patents